Literature DB >> 21889412

Cell-mediated immune responses to inactivated trivalent influenza-vaccination are decreased in patients with common variable immunodeficiency.

Sander van Assen1, Aalzen de Haan, Albert Holvast, Gerda Horst, Linda Gorter, Johanna Westra, Cees G M Kallenberg, Denise S C Telgt, Abraham M Palache, Katinka M Giezeman, Marc Bijl.   

Abstract

Influenza-specific cell-mediated immune (CMI) responses can protect from influenza, but may be decreased in CVID-patients since defects in CMI responses have been demonstrated in CVID-patients. Therefore CMI responses were evaluated in 15 CVID-patients and 15 matched healthy controls (HC) by determining frequencies of interferon (IFN)γ-producing PBMC, and frequencies of IFNγ-, interleukin (IL)-2- and tumour necrosis factor (TNF)α-producing CD4+ and CD8+ T-cells before and after influenza vaccination using IFNγ enzyme-linked immunospot (IFNγ-ELISpot) and flow cytometry. Humoral responses were determined using haemagglutination inhibition assay. In CVID-patients the number of spotforming PBMC in the IFNγ-ELISpot did not increase following influenza vaccination, in contrast to HC. In flow cytometry, the frequencies of IFNγ-producing T-cells decreased in CVID-patients after influenza vaccination, while in HC the frequencies of IFNγ-production flow cytometry increased. Concluding, CMI responses following influenza vaccination are hampered in CVID-patients compared to HC. Additional protective strategies against influenza other than vaccination are warranted.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21889412     DOI: 10.1016/j.clim.2011.07.004

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  9 in total

1.  Common Variable Immunodeficiency Associated with a De Novo IKZF1 Variant and a Low Humoral Immune Response to the SARS-CoV-2 Vaccine.

Authors:  Irene Díaz-Alberola; Andrea Espuch-Oliver; José María García-Aznar; Christian Ganoza-Gallardo; María Aguilera-Franco; Antonio Sampedro; Pilar Jiménez; Miguel Ángel López-Nevot
Journal:  J Clin Med       Date:  2022-04-20       Impact factor: 4.964

2.  Cell mediated immune responses following revaccination with an influenza A/H5N1 vaccine.

Authors:  Innocent N Mbawuike; Robert L Atmar; Shital M Patel; David B Corry; Patricia L Winokur; Rebecca C Brady; Wilbur H Chen; Kathryn M Edwards; C Buddy Creech; Emmanuel B Walter; Sharon E Frey; Robert B Belshe; Johannes B Goll; Heather Hill; Wendy A Keitel
Journal:  Vaccine       Date:  2015-12-04       Impact factor: 3.641

Review 3.  Influenza Vaccination in Patients with Common Variable Immunodeficiency (CVID).

Authors:  Jan F Mieves; Kirsten Wittke; Helma Freitag; Hans-Dieter Volk; Carmen Scheibenbogen; Leif G Hanitsch
Journal:  Curr Allergy Asthma Rep       Date:  2017-10-05       Impact factor: 4.806

4.  Seasonal Influenza Vaccine: Uptake, Attitude, and Knowledge Among Patients Receiving Immunoglobulin Replacement Therapy.

Authors:  Fionnuala Cox; Catherine King; Anne Sloan; David J Edgar; Niall Conlon
Journal:  J Clin Immunol       Date:  2021-01-05       Impact factor: 8.317

5.  Immunogenicity of Anti-SARS-CoV-2 Vaccines in Common Variable Immunodeficiency.

Authors:  Daniel Arroyo-Sánchez; Oscar Cabrera-Marante; Rocío Laguna-Goya; Patricia Almendro-Vázquez; Octavio Carretero; Francisco Javier Gil-Etayo; Patricia Suàrez-Fernández; Pilar Pérez-Romero; Edgard Rodríguez de Frías; Antonio Serrano; Luis M Allende; Daniel Pleguezuelo; Estela Paz-Artal
Journal:  J Clin Immunol       Date:  2021-11-17       Impact factor: 8.317

Review 6.  Overview of Serological Techniques for Influenza Vaccine Evaluation: Past, Present and Future.

Authors:  Claudia Maria Trombetta; Daniele Perini; Stuart Mather; Nigel Temperton; Emanuele Montomoli
Journal:  Vaccines (Basel)       Date:  2014-10-13

7.  Fusarium ramigenum, a novel human opportunist in a patient with common variable immunodeficiency and cellular immune defects: case report.

Authors:  Ruxandra V Moroti; Valeriu Gheorghita; Abdullah M S Al-Hatmi; G Sybren de Hoog; Jacques F Meis; Mihai G Netea
Journal:  BMC Infect Dis       Date:  2016-02-15       Impact factor: 3.090

8.  Assessment of Immunogenicity of Adjuvanted Quadrivalent Inactivated Influenza Vaccine in Healthy People and Patients With Common Variable Immune Deficiency.

Authors:  Aristitsa Mikhailovna Kostinova; Nelli Kimovna Akhmatova; Elena Alexandrovna Latysheva; Yulia Alexeevna Dagil; Svetlana Valentinovna Klimova; Anna Egorovna Vlasenko; Ekaterina Alexandrovna Khromova; Tatyana Vasilievna Latysheva; Mikhail Petrovich Kostinov
Journal:  Front Immunol       Date:  2020-08-19       Impact factor: 7.561

9.  Immunogenicity and Safety of the Quadrivalent Adjuvant Subunit Influenza Vaccine in Seropositive and Seronegative Healthy People and Patients with Common Variable Immunodeficiency.

Authors:  Mikhail P Kostinov; Elena A Latysheva; Aristitsa M Kostinova; Nelly K Akhmatova; Tatyana V Latysheva; Anna E Vlasenko; Yulia A Dagil; Ekaterina A Khromova; Valentina B Polichshuk
Journal:  Vaccines (Basel)       Date:  2020-11-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.